Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Check Point Software Technologies Ltd (CHKP) vs Charles River Laboratories Intl. Inc (CRL) Price & Performance

Check Point Software Technologies LtdTrade
Charles River Laboratories Intl. IncTrade

Price performance (Past 24H)

Key statistics

Check Point Software Technologies Ltd vs Charles River Laboratories Intl. Inc — how do they compare? Check Point Software Technologies Ltd trades at $134.62 (market cap $13.97B), while Charles River Laboratories Intl. Inc trades at $228.74 (market cap $11.14B). The key difference: Check Point Software Technologies Ltd is the larger of the two by market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Check Point Software Technologies Ltd nearer its low. Which is the better fit depends on your goals.

CHKPCRL
Market Cap
$13.97B$11.14B
Sector
TechnologyHealth
52-Week High
$223.00$233.60
52-Week Low
$112.47$145.57
Enterprise Value
$13.17B$14.00B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Check Point Software Technologies Ltd

CHKP trades at $134.32, up 1.99% today, with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with a 38.37% net income margin and trades at a P/E of 13.82. Recent news highlights AI security partnerships and upcoming Q2 2026 earnings on July 30, 2026.

Outlook is mixed: analyst consensus targets $148.43 (10.5% upside) with 46% buy ratings, but technicals and insider sales pose risks. Key catalysts include AI integration progress and earnings results, while competition and sector volatility remain headwinds.

Charles River Laboratories Intl. Inc

Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.

Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Check Point Software Technologies Ltd

Check Point is a global leader in cybersecurity solutions. It provides comprehensive protection against advanced cyber threats for corporate networks, cloud environments, mobile devices, and critical infrastructure.

Read more on CHKP

About Charles River Laboratories Intl. Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Read more on CRL